Skip to main navigation
Skip to search
Skip to main content
Welcome to DTU Research Database Home
About DTU Orbit
Home
Profiles
Research units
Publications
Activities
Projects
Prizes
Press/Media
Datasets
Search by expertise, name or affiliation
Development of advanced microbial therapeutics for treating metabolic and hormone-related diseases
Gelli Praveenkumar, Hitesh
(PhD Student)
Sommer, Morten Otto Alexander
(Main Supervisor)
Vazquez Uribe, Ruben
(Supervisor)
Nielsen, Hanne Mørck
(Supervisor)
Sommer, Morten Otto Alexander
(Main Supervisor)
Vazquez Uribe, Ruben
(Supervisor)
Buckley, Stephen T.
(Examiner)
Crook, Nathan
(Examiner)
Nielsen, Hanne Mørck
(Supervisor)
DTU Microbes Initiative
Bacterial Synthetic Biology
Novo Nordisk Foundation Center for Biosustainability
Overview
Fingerprint
Publications
(1)
Project Details
Status
Finished
Effective start/end date
01/04/2021
→
14/01/2025
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Fibroblast Growth Factor 21
Pharmacology, Toxicology and Pharmaceutical Science
100%
Albumin Fusion
Keyphrases
83%
Fibroblast Growth Factor 21 (FGF21)
Keyphrases
83%
Research output
Publications per year
2024
2024
2024
1
Ph.D. thesis
Publications per year
Publications per year
Advanced microbial therapeutics (AMTs) for enhanced
in situ
delivery of therapeutic peptides and proteins
Gelli Praveenkumar, H.
,
2024
,
155 p.
Research output
:
Book/Report
›
Ph.D. thesis
Open Access
File
Fibroblast Growth Factor 21
100%
Albumin Fusion
83%
Fibroblast Growth Factor 21 (FGF21)
83%
33
Downloads (Pure)